Ann Pediatr Endocrinol Metab.  2021 Jun;26(2):80-85. 10.6065/apem.2040242.121.

Subclinical hypothyroidism in children: updates for pediatricians

• Metwalley KA
• Farghaly HS

• KMID: 2517584
• DOI: http://doi.org/10.6065/apem.2040242.121

Abstract

Subclinical hypothyroidism (SH) is defined as serum thyroid-stimulating hormone (TSH) above the upper limit of the reference range in the presence of normal free T4 concentrations. Depending on the degree of TSH elevation, SH could be defined as mild (TSH, 4.5–10 mIU/L) or severe (TSH>10 mIU/L). While there is a general consensus to treat children with serum TSH levels above 10 mU/L, the management of the mild form is uncertain and should be individualized. In this mini-review, we present a brief review of SH in children based on extensive literature review and long-standing clinical experience. This review provides the prevalence, causes, clinical presentation, consequences, investigation, and up-to-date therapeutic approach of SH in children. Generally, the purpose of the review is to provide pediatricians with an update of this common and continuously evolving condition.

Keyword

Subclinical hypothyroidism; Hashimoto’s thyroiditis; Thyroid-stimulating hormone; Thyroid autoantibodies; Levothyroxine

Reference

References

1. Crisafulli G, Aversa T, Zirilli G, Pajno GB, Corica D, De Luca F, et al. Subclinical hypothyroidism in children: when a replacement hormonal treatment might be advisable. Front Endocrinol (Lausanne). 2019; 10:109.

2. Van Deventer HE, Mendu DR, Remaley AT, Soldin SJ. Inverse log-linear relationship between thyroid-stimulating hormone and free thyroxine measured by direct analog immunoassay and tandem mass spectrometry. Clin Chem. 2011; 57:122–7.

3. Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019; 322:153–60.

4. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012; 379:1142–54.

5. Salerno M, Capalbo D, Cerbone M, De Luca F. Subclinical hypothyroidism in childhood - current knowledge and open issues. Nat Rev Endocrinol. 2016; 12:734–46.

6. Gopalakrishnan S, Chugh PK, Chhillar M, Ambardar VK, Sahoo M, Sankar R. Goitrous autoimmune thyroiditis in a pediatric population: a longitudinal study. Pediatrics. 2008; 122:e670–4.

7. Lee YJ, Jung SY, Jung HW, Kim SY, Lee YA, Lee SY, et al. Unfavorable course of subclinical hypothyroidism in children with Hashimoto’s thyroiditis compared to those with isolated non-autoimmune hyperthyrotropinemia. J Korean Med Sci. 2017; 32:124–9.

8. Brown RS. Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol. 2013; 5 Suppl 1:45–9.

9. Nicoletti A, Bal M, De Marco G, Baldazzi L, Agretti P, Menabo S, et al. Thyrotropin-stimulating hormone receptor gene analysis in pediatric patients with non-autoimmune subclinical hypothyroidism. J Clin Endocrinol Metab. 2009; 94:4187–94.

10. Abe K, Narumi S, Suwanai AS, Adachi M, Muroya K, Asakura Y, et al. Association between monoallelic TSHR mutations and congenital hypothyroidism: a statistical approach. Eur J Endocrinol. 2018; 178:137–44.

11. Cassio A, Nicoletti A, Rizzello A, Zazzetta E, Bal M, Baldazzi L. Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment. J Clin Res Pediatr Endocrinol. 2013; 5 Suppl 1:29–39.

12. De Marco G, Agretti P, Montanelli L, Di Cosmo C, Bagattini B, De Servi M, et al. Identification and functional analysis of novel dual oxidase 2 (DUOX2) mutations in children with congenital or subclinical hypothyroidism. J Clin Endocrinol Metab. 2011; 96:E1335–9.

13. King K, O’Gorman C, Gallagher S. Thyroid dysfunction in children with Down syndrome: a literature review. Ir J Med Sci. 2014; 183:1–6.

14. Aversa T, Salerno M, Radetti G, Faienza MF, Iughetti L, Corrias A, et al. Peculiarities of presentation and evolution over time of Hashimoto's thyroiditis in children and adolescents with Down's syndrome. Hormones. 2015; 14:410–6.

15. Grossi A, Crinò A, Luciano R, Lombardo A, Cappa M, Fierabracci A. Endocrine autoimmunity in Turner syndrome. Ital J Pediatr. 2013; 39:79.

16. Deladoëy J, Ruel J, Giguère Y, Van Vliet G. Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Québec. J Clin Endocrinol Metab. 2011; 96:2422–9.

17. Buluş AD, Tiftik E. Evaluation of neurodevelopment of children with congenital hypothyroidism by the Denver Developmental Screening Test. J Pediatr Endocrinol Metab. 2017; 30:1061–6.

18. Reinehr T. Thyroid function in the nutritionally obese child and adolescent. Curr Opin Pediatr. 2011; 23:415–20.

19. Reinehr T, Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis Child. 2002; 87:320–3.

20. Gökdeniz E, Demir C, Dilek I. The effects of iron deficiency anemia on the thyroid functions. J Clin Exp Invest. 2010; 1:156–60.

21. Metwalley KA, Farghaly HS, Hassan AF. Thyroid status in Egyptian primary school children with iron deficiency anemia: relationship to intellectual function. Thyroid Res Pract. 2013; 10:91–5.

22. Af roz S, K han AH, R oy DK. Thyroid f unction in children with nephrotic syndrome. Mymensingh Med J. 2011; 20:407–11.

23. Benvenga S, Vita R, Di Bari F, Fallahi P, Antonelli A. Do not forget nephrotic syndrome as a cause of increased requirement of levothyroxine replacement therapy. Eur Thyroid J. 2015; 4:138–42.

24. Lazar L, Frumkin RB, Battat E, Lebenthal Y, Phillip M, Meyerovitch J. Natural history of thyroid function tests over 5 years in a large pediatric cohort. J Clin Endocrinol Metab. 2009; 94:1678–82.

25. Wasniewska M, Salerno M, Cassio A, Corrias A, Aversa T, Zirilli G, et al. Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence. Eur J Endocrinol. 2009; 160:417–21.

26. Shrestha U, Gautam N, Agrawal KK, Jha AC, Jayan A. Iodine status among subclinical and overt hypothyroid patients by urinary iodine assay: a case-control study. Indian J Endocrinol Metab. 2017; 21:719–23.

27. Kang MJ, Hwang IT, Chung HR. Excessive iodine intake and subclinical hypothyroidism in children and adolescents aged 6-19 years: results of the Sixth Korean National Health and Nutrition Examination Survey, 2013-2015. Thyroid. 2018; 28:773–9.

28. Chemaitilly W, Cohen LE. Diagnosis of endocrine disease: endocrine late-effects of childhood cancer and its treatments. Eur J Endocrinol. 2017; 176:R183–203.

29. Rosene ML, Wittmann G, Arrojo e Drigo R, Singru PS, Lechan RM, Bianco AC. Inihibition of type 2 iodothyronine diodinase underlies the elevated plasma TSH associated with amiodarone treatment. Endocrinology. 2010; 151:5961–70.

30. Tomer Y, Menconi F. Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab. 2009; 23:703–12.

31. Benedetti MS, Whomsley R, Baltes E, Tonner F. Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction. Eur J Clin Phamacol. 2005; 61:863–72.

32. Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014; 24:1456–65.

33. Marks SD. Nonthyroidal illness syndrome in children. Endocrine. 2009; 36:355–67.

34. Stockigt J. Assessment of thyroid function: towards an integrated laboratory--clinical approach. Clin Biochem Rev. 2003; 24:109–22.

35. Favresse J, Burlacu MC, Maiter D, Gruson D. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev. 2018; 39:830–50.

36. Hattori N, Ishihara T, Matsuoka N, Saito T, Shimatsu A. Anti-thyrotropin autoantibodies in patients with macrothyrotropin and long-term changes in macro-thyrotropin and serum thyrotropin levels. Thyroid. 2017; 27:138–46.

37. Roelfsema F, Veldhuis JD. Thyrotropin secretion patterns in health and disease. Endocr Rev. 2013; 34:619–57.

38. Scobbo RR, VonDohlen TW, Hassan M, Islam S. Serum TSH variability in normal individuals: the influence of time of sample collection. W V Med J. 2004; 100:138–42.

39. Benvenga S, Di Bari F, Granese R, Antonelli A. Serum thyrotropin and phase of the menstrual cycle. Front Endocrinol (Lausanne). 2017; 29;8:250.

40. Gary KA, Winokur A, Douglas SD, Kapoor S, Zaugg L, Dinges DF. Total sleep deprivation and the thyroid axis: effects of sleep and waking activity. Aviat Space Environ Med. 1996; 67:513–9.

41. Chaudhary V, Bano S. Thyroid ultrasound. Indian J Endocrinol Metab. 2013; 17:219–27.

42. Bauer AJ, Francis GL. Evaluation and management of thyroid nodules in children. Curr Opin Pediatr. 2016; 28:536–44.

43. Ittermann T, Thamm M, Wallaschofski H, Rettig R, Völzke H. Serum thyroid stimulating hormone levels are associated with blood pressure in children and adolescents. Clin Endocrinol Metab. 2012; 97:828–3.

44. Çatlı G, Kır M, Anık A, Yılmaz N, Böber E, Abacı A. The effect of L thyroxine treatment on left ventricular functions in children with subclinical hypothyroidism. Arch Dis Child. 2015; 100:130–7.

45. Tacito LHB, Pires AC, Yugar-Toledo JC. Impaired flowmediated dilation response and carotid intima-media thickness in patients with type 1 diabetes mellitus with a mean disease duration of 4.1 years. Arch Endocrinol Metab. 2017; 61:542–9.

46. Bachar GN, Dicker D, Kornowski R, Atar E. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol. 2012; 110:534–53.

47. Farghaly HS, Metwalley KA, Raafat DM, Algowhary M, Said GM. Epicardial fat thickness in children with subclinical hypothyroidism and its relationship to subclinical atherosclerosis: a pilot study. Horm Res Paediatr. 2019; 92:99–105.

48. Cerbone M, Capalbo D, Wasniewska M, Mattace Raso G, Alfano S, Meli R, et al. Cardiovascular risk factors in children with long-standing untreated idiopathic subclinical hypothyroidism. J Clin Endocrinol Metab. 2014; 99:2697–703.

49. Cerbone M, Bravaccio C, Capalbo D, Polizzi M, Wasniewska M, Cioffi D, et al. Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol. 2011; 164:591–7.

50. Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, et al. L -thyroxine- treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross sectional study on 27,914 patients. Endocr Relat Cancer. 2010; 17:231–9.